535 related articles for article (PubMed ID: 29526163)
1. Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Leão R; Apolónio JD; Lee D; Figueiredo A; Tabori U; Castelo-Branco P
J Biomed Sci; 2018 Mar; 25(1):22. PubMed ID: 29526163
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
Vahidi S; Norollahi SE; Agah S; Samadani AA
J Gastrointest Cancer; 2020 Sep; 51(3):788-799. PubMed ID: 32617831
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Stögbauer L; Stummer W; Senner V; Brokinkel B
Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
5. Physiological and pathological significance of human telomerase reverse transcriptase splice variants.
Bollmann FM
Biochimie; 2013 Nov; 95(11):1965-70. PubMed ID: 23933091
[TBL] [Abstract][Full Text] [Related]
6. Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer.
Yang R; Han Y; Guan X; Hong Y; Meng J; Ding S; Long Q; Yi W
Cell Commun Signal; 2023 Aug; 21(1):218. PubMed ID: 37612721
[TBL] [Abstract][Full Text] [Related]
7. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targets in Telomerase and Telomere Biology of Cancers.
Prasad R; Pal D; Mohammad W
Indian J Clin Biochem; 2020 Apr; 35(2):135-146. PubMed ID: 32226245
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
Yuan X; Larsson C; Xu D
Oncogene; 2019 Aug; 38(34):6172-6183. PubMed ID: 31285550
[TBL] [Abstract][Full Text] [Related]
10. Zinc sulfate contributes to promote telomere length extension via increasing telomerase gene expression, telomerase activity and change in the TERT gene promoter CpG island methylation status of human adipose-derived mesenchymal stem cells.
Farahzadi R; Fathi E; Mesbah-Namin SA; Zarghami N
PLoS One; 2017; 12(11):e0188052. PubMed ID: 29145503
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
Horikawa I; Barrett JC
Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
[TBL] [Abstract][Full Text] [Related]
12. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
Guilleret I; Benhattar J
Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
[TBL] [Abstract][Full Text] [Related]
13. TERT-Regulation and Roles in Cancer Formation.
Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
Front Immunol; 2020; 11():589929. PubMed ID: 33329574
[TBL] [Abstract][Full Text] [Related]
14. Regulation of telomerase and its hTERT messenger in colorectal cancer.
Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation of the TERT promoter and its impact on human cancer.
Lee DD; Komosa M; Nunes NM; Tabori U
Curr Opin Genet Dev; 2020 Feb; 60():17-24. PubMed ID: 32114294
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
[TBL] [Abstract][Full Text] [Related]
18. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.
Kyo S; Takakura M; Fujiwara T; Inoue M
Cancer Sci; 2008 Aug; 99(8):1528-38. PubMed ID: 18754863
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
20. TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression.
Lafferty-Whyte K; Bilsland A; Hoare SF; Burns S; Zaffaroni N; Cairney CJ; Keith WN
Neoplasia; 2010 May; 12(5):405-14. PubMed ID: 20454512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
